+91 8483 9659 21 (APAC)

+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)

sales@researchlayer.com
  1. Home
  2. Chemicals and Material
  3. Global Personalized Medicine Market Research Report—Forecast till 2032

Global Personalized Medicine Market Research Report: Information By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, and Others), By End Use (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest of The World) –Market Forecast Till 2032.

  •  Region : Global
  • Chemicals and Material
  • Published Report
  • Aug 2023
  •  Pages : 300
  •  Format : PDF/Excel
  •  Report ID : RL65100

Table of Contents

1.    Executive summary

2.    Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1.  Research Objective

2.2.2.  Assumptions

2.2.3.  Limitations         

3.    Research Methodology

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1.         Primary Interviews and Information Gathering Process

3.4.2.         Breakdown of Primary Respondents  

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1.         Bottom-Up Approach

3.6.2.         Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4.    Market Dynamics

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5.    Market Factor Analysis

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1.  Bargaining Power of Suppliers

5.2.2.  Bargaining Power of Buyers

5.2.3.  Threat of New Entrants

5.2.4.  Threat of Substitutes

5.2.5.  Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1.  Market Impact Analysis

5.3.2.  Regional Impact

5.3.3.  Opportunity and Threat Analysis

6.    GLOBAL Personalized Medicine MARKET, BY Product

6.1. Overview

6.2. Personalized Medicine Diagnostics

6.3. Personalized Medicine Therapeutics

6.4. Personalized Medical Care

6.5. Personalized Nutrition and Wellness

7.    GLOBAL Personalized Medicine MARKET, BY Application

7.1. Overview

7.2. Oncology

7.3. CNS

7.4. Immunology

7.5. Respiratory

7.6. Others 

8.    GLOBAL Personalized Medicine MARKET, BY End-use

8.1. Overview

8.2. Hospitals

8.3. Diagnostic Centers

8.4. Research & Academic Institutes

8.5. Others

9.    GLOBAL Personalized Medicine MARKET, by Region

9.1. Overview

9.2. North America

9.2.1.         U.S.

9.2.2.         Canada

9.3. Europe

9.3.1.         Germany

9.3.2.         France

9.3.3.         U.K

9.3.4.         Italy

9.3.5.         Spain

9.3.6.         Rest of Europe

9.4. Asia-Pacific

9.4.1.         China

9.4.2.         India

9.4.3.         Japan

9.4.4.         South Korea

9.4.5.         Australia

9.4.6.         Rest of Asia-Pacific

9.5. Rest of the World

9.5.1.         Middle East

9.5.2.         Africa

9.5.3.         Latin America

10. Competitive Landscape

10.1. Overview         

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Personalized Medicine Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Personalized Medicine Market,

10.7. Key developments and Growth Strategies

10.7.1.                      New Product Launch/Application Deployment

10.7.2.                      Merger & Acquisitions

10.7.3.                      Joint Ventures

10.8. Major Players Financial Matrix

10.8.1.      Sales & Operating Income, 2022

10.8.2.      Major Players R&D Expenditure. 2022

11. Company ProfileS

11.1. Illumina Inc.

11.1.1.                      Company Overview

11.1.2.                      Financial Overview

11.1.3.                      Products Offered

11.1.4.                      Key Developments

11.1.5.                      SWOT Analysis

11.1.6.                      Key Strategies

11.2. Precision Biologics

11.2.1.                      Company Overview

11.2.2.                      Financial Overview

11.2.3.                      Products Offered

11.2.4.                      Key Developments

11.2.5.                      SWOT Analysis

11.2.6.                      Key Strategies

11.3. Danaher Corporation

11.3.1.                      Company Overview

11.3.2.                      Financial Overview

11.3.3.                      Products Offered

11.3.4.                      Key Developments

11.3.5.                      SWOT Analysis

11.3.6.                      Key Strategies

11.4. GE Healthcare

11.4.1.                      Company Overview

11.4.2.                      Financial Overview

11.4.3.                      Products Offered

11.4.4.                      Key Developments

11.4.5.                      SWOT Analysis

11.4.6.                      Key Strategies

11.5. Celera Diagnostics LLC

11.5.1.                      Company Overview

11.5.2.                      Financial Overview

11.5.3.                      Products Offered

11.5.4.                      Key Developments

11.5.5.                      SWOT Analysis

11.5.6.                      Key Strategies

11.6. DECODE GENETICS INC.

11.6.1.                      Company Overview

11.6.2.                      Financial Overview

11.6.3.                      Products Offered

11.6.4.                      Key Developments

11.6.5.                      SWOT Analysis

11.6.6.                      Key Strategies

11.7. Exact Sciences Corporation

11.7.1.                      Company Overview

11.7.2.                      Financial Overview

11.7.3.                      Products Offered

11.7.4.                      Key Developments

11.7.5.                      SWOT Analysis

11.7.6.                      Key Strategies

11.8. IBM Corporation

11.8.1.                      Company Overview

11.8.2.                      Financial Overview

11.8.3.                      Products Offered

11.8.4.                      Key Developments

11.8.5.                      SWOT Analysis

11.8.6.                      Key Strategies

11.9. Exagen Inc.

11.9.1.                      Company Overview

11.9.2.                      Financial Overview

11.9.3.                      Products Offered

11.9.4.                      Key Developments

11.9.5.                      SWOT Analysis

11.9.6.                      Key Strategies

11.10. Biogen

11.10.1.                   Company Overview

11.10.2.                   Financial Overview

11.10.3.                   Products Offered

11.10.4.                   Key Developments

11.10.5.                   SWOT Analysis

11.10.6.                   Key Strategies

12. Appendix

12.1. References

12.2. Related Reports

 

 

LIST OF TABLES

TABLE 1                 Global Personalized Medicine Market, Synopsis, 2018-2032

TABLE 2                 Global Personalized Medicine Market, Estimates & Forecast, 2018-2032 (USD BILLION)

TABLE 3                 GLOBAL Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 4                 GLOBAL Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5                 GLOBAL Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 6                 North America Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 7                 North America Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8                 North America Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 9                 North America Personalized Medicine MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 10             U.S. Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 11             U.S. Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 12             U.S. Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 13             Canada Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 14             Canada Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15             Canada Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 16             Europe Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 17             Europe Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 18             Europe Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 19             Europe Personalized Medicine MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 20             Germany Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 21             Germany Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 22             Germany Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 23             France Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 24             France Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25             France Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 26             Italy Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 27             Italy Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 28             Italy Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 29             Spain Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 30             Spain Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31             Spain Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 32             U.K Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 33             U.K Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 34             U.K Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 35             Rest of Europe Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 36             Rest of Europe Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 37             Rest of Europe Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 38             Asia Pacific Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 39             Asia Pacific Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 40             Asia Pacific Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 41             Asia Pacific Personalized Medicine MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 42             Japan Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 43             Japan Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44             Japan Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 45             China Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 46             China Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47             China Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 48             India Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 49             India Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50             India Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 51             Australia Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 52             Australia Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53             Australia Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 54             south korea Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 55             south korea Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 56             south korea Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 57             Rest of asia-pacific Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 58             Rest of asia-pacific Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 59             Rest of asia-pacific Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 60             Rest of WOrld Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 61             Rest of WOrld Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62             Rest of WOrld Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 63             Rest of WOrld Personalized Medicine MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 64             Middle east Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 65             Middle east Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 66             Middle east Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 67             Africa Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 68             Africa Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 69             Africa Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

TABLE 70             Latin america Personalized Medicine MARKET, BY Product, 2018-2032 (USD BILLION)

TABLE 71             Latin america Personalized Medicine MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 72             Latin america Personalized Medicine MARKET, BY END-USE, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1             Research Process

FIGURE 2             Market Structure for the Global Personalized Medicine Market

FIGURE 3             Market Dynamics for the Global Personalized Medicine Market

FIGURE 4             Global Personalized Medicine Market, Share (%), BY Product, 2022

FIGURE 5             Global Personalized Medicine Market, Share (%), BY APPLICATION, 2022

FIGURE 6             Global Personalized Medicine Market, Share (%), BY END-USE, 2022

FIGURE 7             Global Personalized Medicine Market, Share  (%), by Region, 2022

FIGURE 8             north AMERICA: Personalized Medicine MARKET, SHARE (%), BY REGION, 2022

FIGURE 9             Europe: Personalized Medicine MARKET, SHARE (%), BY REGION, 2022

FIGURE 10         Asia-Pacific: Personalized Medicine MARKET, SHARE  (%), BY REGION, 2022

FIGURE 11         Rest of the world: Personalized Medicine MARKET, SHARE (%), BY REGION, 2022

FIGURE 12         Global Personalized Medicine Market: Company Share Analysis, 2022 (%)

FIGURE 13         Illumina Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14         Illumina Inc.: SWOT ANALYSIS

FIGURE 15         Precision Biologics: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16         Precision Biologics: SWOT ANALYSIS

FIGURE 17         Danaher Corporation: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18         Danaher Corporation: SWOT ANALYSIS

FIGURE 19         GE Healthcare: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20         GE Healthcare: SWOT ANALYSIS

FIGURE 21         Celera Diagnostics LLC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22         Celera Diagnostics LLC.: SWOT ANALYSIS

FIGURE 23         DECODE GENETICS INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24         DECODE GENETICS INC.: SWOT ANALYSIS

FIGURE 25         Exact Sciences Corporation: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26         Exact Sciences Corporation: SWOT ANALYSIS

FIGURE 27         IBM Corporation: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28         IBM Corporation: SWOT ANALYSIS

FIGURE 29         Exagen Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30         Exagen Inc.: SWOT ANALYSIS

FIGURE 31         Biogen: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32         Biogen: SWOT ANALYSIS

 

Global Personalized Medicine Market Research Report: Information By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, and Personalized Nutrition and Wellness), By Application (Oncology, CNS, Immunology, Respiratory, and Others), By End Use (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, and Rest of The World) –Market Forecast Till 2032.  

Report Code :
RL65100
Published on :
Aug 2023
Request a Free Sample Report


CHOOSE LICENCE TYPE
  • :   $3749   
  • :   $5549   
  • :   $7549   

Latest Reports
Press Release
Get 10% Free Customization
 On This ReportPrint

Print     Speak to Analyst
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your format and defination
  • Gain Deeper Dive on a Specific Application,Geography,Customer or Computer
  • Any Level of Personalization
    •
    Why Choose Us
       

    Our Clients

    electronic and semiconductor      electronic and semiconductor      C2C      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      SELENIS       electronic and semiconductor            electronic and semiconductor      electronic and semiconductor      electronic and semiconductor      electronic and semiconductor       mips protection       Opulent International       SELENIS       inkuy       MIVV      GSPANN      ANI CO., LTD      C2C      C2C      C2C      C2C      C2C